India’s Healthcare Business Daily
Search the archive
Key Coverage
Follow IndiaMedToday
Topic
1 article
The randomised, double-blind, placebo-controlled US Phase 2 proof-of-concept study with opaganib enrolled 40 patients requiring oxygen support RedHill Biopharma, a…